A double-stranded polynucleotide-ε-polylysine complex with immunoregulatory effect and its preparation and use method

A double-stranded polynucleotide and polylysine technology, applied in biochemical equipment and methods, medical preparations containing active ingredients, microorganisms, etc., can solve problems such as antibiotic residues and achieve strong resistance to biological enzymatic degradation , Improving immune regulation activity, and the effect of simple preparation process

Active Publication Date: 2019-01-18
北京加益维科生物科技有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0047] In 1969, the Chinese Academy of Sciences collaborated with relevant units to creatively use a new formulation, and developed a new polymuscular cell complex formulation, that is, adding kanamycin sulfate containing polyamide positive ions on the basis of PIC to Protect the double-strand structure from rapid hydrolysis by nucleases and maintain good stability so that it can play its due role. Because the molecular weight of kanamycin sulfate is smaller than that of polylysine with a molecular weight of tens of thousands or hundreds of thousands much, so the side effects are much lower, but the use of kanamycin is likely to cause problems such as antibiotic residues

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A double-stranded polynucleotide-ε-polylysine complex with immunoregulatory effect and its preparation and use method
  • A double-stranded polynucleotide-ε-polylysine complex with immunoregulatory effect and its preparation and use method
  • A double-stranded polynucleotide-ε-polylysine complex with immunoregulatory effect and its preparation and use method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] a, 0.1mol / L calcium chloride solution preparation:

[0093] Weigh 1.110 g of anhydrous calcium chloride and dissolve it in 100 ml of water for injection, and filter and sterilize through a filter membrane with a pore size of 0.2 μm to prepare a 0.1 mol / L calcium chloride solution.

[0094] b. Preparation of 0.01mol / L PBS solution (pH=7.6):

[0095] Weigh 0.124g of disodium hydrogen phosphate, 0.018g of sodium dihydrogen phosphate monohydrate, and 0.808g of sodium chloride respectively, dissolve them in 100ml of water for injection after mixing, and filter and sterilize through a filter membrane with a pore size of 0.2μm to make 0.01mol / L PBS solution (pH=7.6).

[0096] c. Preparation of 2mg / ml PolyIC intermediate solution:

[0097] Weigh 1.0088g of PolyI and 0.9912g of PolyC and add 400ml of PBS solution to dissolve, combine the two liquids, mix and shake well, add PBS solution to 1000ml, place in 45°C water bath for 60 minutes, and pass through a filter membrane with...

Embodiment 2

[0105] a, 0.1mol / L calcium chloride solution preparation:

[0106] Weigh 1.110 g of anhydrous calcium chloride and dissolve it in 100 ml of water for injection, and filter and sterilize through a filter membrane with a pore size of 0.2 μm to prepare a 0.1 mol / L calcium chloride solution.

[0107] b. Preparation of 0.01mol / L PBS solution (pH=7.6):

[0108] Weigh 0.124g of disodium hydrogen phosphate, 0.018g of sodium dihydrogen phosphate monohydrate, and 0.808g of sodium chloride respectively, dissolve them in 100ml of water for injection after mixing, and filter and sterilize through a filter membrane with a pore size of 0.2μm to make 0.01mol / L PBS solution (pH=7.6).

[0109] c, 2mg / ml preparation of bursal virus RNA solution:

[0110] The bursal virus RNA was dissolved in PBS buffer, and sterilized by filtration through a filter membrane with a pore size of 0.45 μm to prepare a 2 mg / ml solution for later use.

[0111] d. Preparation of 10mg / ml ε‐polylysine solution:

[01...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a double-strand oligonucleotide-epsilon-polylysine compound with an immune regulation function and a preparation and use method of the double-strand oligonucleotide-epsilon-polylysine compound and also provides immunogen composition with functions of triggering immunoenhancement reaction and changing the immunoreaction type and a preparation and use method of the immunogen composition. The immunogen composition comprises the double-strand oligonucleotide-epsilon-polylysine compound and an antigen. The compound contains a compound formed through composition of double-stranded polynucleotide, a cation epsilon-polylysine and metal cations. The compound has the pharmacological activity of immunoregulation. The preparation process of the compound is simple. The compound has good water solubility and a bio-enzyme degradation resisting function. The immunogen composition can trigger the immunoenhancement reaction and change the immunoreaction type.

Description

technical field [0001] The present invention relates to the field of medicine, specifically, the present invention provides a double-stranded polynucleotide-ε-polylysine complex with immune regulation function and its preparation and use method. The present invention also provides an immunogen composition capable of triggering and enhancing immune response and changing the type of immune response and its preparation and use method. Background technique [0002] 1. Double-stranded polynucleotide: Double-stranded polynucleotide or its derivatives have various pharmacological activities, and the source is natural extraction or artificial synthesis. Artificially synthesized double-stranded polynucleotides such as polyinocytic (polyI:C) can induce the production of interferon in the body, protect cells from virus infection, and have curative effects such as preventing and treating viral diseases; naturally extracted double-stranded polynucleotides such as Viral double-stranded R...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/39A61K39/12
CPCA61K39/12A61K39/39A61K2039/55511A61K2039/55583C12N2760/20134
Inventor 苏文全
Owner 北京加益维科生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap